THC Therapeutics Inc
THC Therapeutics, Inc. operates in the wellness industry. It develops dHydronator, a sanitizing herb/cannabis dryer. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was founded in 2007 and is based in Jacksboro, Texas.
THC Therapeutics Inc (THCT) - Net Assets
Latest net assets as of October 2024: $-3.52 Million USD
Based on the latest financial reports, THC Therapeutics Inc (THCT) has net assets worth $-3.52 Million USD as of October 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.81K) and total liabilities ($3.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.52 Million |
| % of Total Assets | -29796.25% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 348.72 |
THC Therapeutics Inc - Net Assets Trend (2007–2024)
This chart illustrates how THC Therapeutics Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for THC Therapeutics Inc (2007–2024)
The table below shows the annual net assets of THC Therapeutics Inc from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-07-31 | $-3.31 Million | 0.00% |
| 2023-07-31 | $-3.31 Million | -6.43% |
| 2022-07-31 | $-3.11 Million | -25.54% |
| 2021-07-31 | $-2.48 Million | -39.28% |
| 2020-07-31 | $-1.78 Million | -137.34% |
| 2019-07-31 | $-749.41K | -138.67% |
| 2018-07-31 | $1.94 Million | -60.03% |
| 2017-07-31 | $4.85 Million | +3456.30% |
| 2016-07-31 | $-144.46K | +47.94% |
| 2015-07-31 | $-277.46K | -47.18% |
| 2014-07-31 | $-188.52K | -501.10% |
| 2013-07-31 | $47.00K | -77.19% |
| 2012-07-31 | $206.01K | +612.93% |
| 2010-07-31 | $-40.16K | +41.37% |
| 2009-07-31 | $-68.51K | -1003.59% |
| 2008-07-31 | $7.58K | -52.82% |
| 2007-07-31 | $16.07K | -- |
Equity Component Analysis
This analysis shows how different components contribute to THC Therapeutics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3842379200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $32.75K | % |
| Other Comprehensive Income | $-6.15 Million | % |
| Other Components | $41.23 Million | % |
| Total Equity | $-3.31 Million | 100.00% |
THC Therapeutics Inc Competitors by Market Cap
The table below lists competitors of THC Therapeutics Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pender Street Capital Corp.
V:PCP-P
|
$8.92K |
|
NINE DRAGONS PAPER
MU:N3Y
|
$8.92K |
|
Lion Capital S.A.
RO:LION
|
$8.92K |
|
Ha Noi Education Development And Investment JSC
VN:EID
|
$8.92K |
|
Cabo Drilling Corp
PINK:CBEEF
|
$8.91K |
|
Attock Cement Pakistan Ltd
KAR:ACPL
|
$8.90K |
|
Fortune Valley Treasures Inc
PINK:FVTI
|
$8.90K |
|
Acmepoint Energy Services Co.,LTD
TWO:6692
|
$8.89K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in THC Therapeutics Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -3,309,833 to -3,309,833, a change of 0.
- Net loss of 387,036 reduced equity.
- Other comprehensive income decreased equity by 6,149,772.
- Other factors increased equity by 6,536,808.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-387.04K | -11.69% |
| Other Comprehensive Income | $-6.15 Million | -185.8% |
| Other Changes | $6.54 Million | +197.5% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares THC Therapeutics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-07-31 | $0.03 | $0.00 | x |
| 2008-07-31 | $0.01 | $0.00 | x |
| 2009-07-31 | $-0.12 | $0.00 | x |
| 2010-07-31 | $-0.04 | $0.00 | x |
| 2011-07-31 | $-0.03 | $0.00 | x |
| 2012-07-31 | $0.80 | $0.00 | x |
| 2014-07-31 | $-0.35 | $0.00 | x |
| 2015-07-31 | $-0.51 | $0.00 | x |
| 2016-07-31 | $-0.25 | $0.00 | x |
| 2017-07-31 | $0.74 | $0.00 | x |
| 2018-07-31 | $0.16 | $0.00 | x |
| 2019-07-31 | $-0.06 | $0.00 | x |
| 2020-07-31 | $-0.11 | $0.00 | x |
| 2021-07-31 | $-0.08 | $0.00 | x |
| 2022-07-31 | $-0.09 | $0.00 | x |
| 2023-07-31 | $-0.10 | $0.00 | x |
| 2024-07-31 | $-0.10 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently THC Therapeutics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-51.10%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | -0.95% | -76.50% | 0.01x | 1.06x | $-1.76K |
| 2008 | -111.98% | 0.00% | 0.00x | 1.20x | $-9.25K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-62.02K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-33.85K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-18.28K |
| 2012 | -117.25% | 0.00% | 0.00x | 2.89x | $-262.15K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-557.19K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-256.55K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-77.55K |
| 2017 | -321.72% | 0.00% | 0.00x | 1.06x | $-16.08 Million |
| 2018 | -316.78% | 0.00% | 0.00x | 1.30x | $-6.33 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-23.54 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.75 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.64 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.21 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-56.05K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-56.05K |
Industry Comparison
This section compares THC Therapeutics Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| THC Therapeutics Inc (THCT) | $-3.52 Million | -0.95% | N/A | $8.92K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |